HomeAbout

TL;DR CNBC


Abbott launches its first over-the-counter continuous glucose monitor in the U.S. - TL;DR CNBC

Abbott launches its first over-the-counter continuous glucose monitor in the U.S.

Publishing timestamp: 2024-09-05 09:00:01


Summary

Abbott Laboratories has announced the availability of its over-the-counter continuous glucose monitor Lingo in the U.S. The device is aimed at adults who do not take insulin and want to improve their overall health and wellness. Users can purchase sensors starting at $49 and wear them on their upper arm for up to 14 days. The device helps users monitor their glucose levels in real-time and learn about their body's response to food, exercise, sleep, and stress.


Sentiment: POSITIVE

Tickers: ABT

Keywords: united statesbusiness newsabbott laboratoriestechnologyhealth care industrybreaking news: technology

Source: https://www.cnbc.com/2024/09/05/-abbott-launches-its-first-over-the-counter-continuous-glucose-monitor-in-the-us.html


Developed by Leo Phan